WO2004108128A1 - Utilisation de bullatacine dans la fabrication de medicaments anti-sida - Google Patents

Utilisation de bullatacine dans la fabrication de medicaments anti-sida Download PDF

Info

Publication number
WO2004108128A1
WO2004108128A1 PCT/CN2004/000611 CN2004000611W WO2004108128A1 WO 2004108128 A1 WO2004108128 A1 WO 2004108128A1 CN 2004000611 W CN2004000611 W CN 2004000611W WO 2004108128 A1 WO2004108128 A1 WO 2004108128A1
Authority
WO
WIPO (PCT)
Prior art keywords
medicaments
bullatacin
manufacturing
aids virus
suppressing
Prior art date
Application number
PCT/CN2004/000611
Other languages
English (en)
Chinese (zh)
Inventor
Peng Yang
Fan Yang
Original Assignee
Peng Yang
Fan Yang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peng Yang, Fan Yang filed Critical Peng Yang
Publication of WO2004108128A1 publication Critical patent/WO2004108128A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation de bullatacine dans la fabrication de médicaments anti-SIDA. Son mécanisme d'action diffère de celui des traitements cliniques utilisés pour soigner les infections à HIV/SIDA. Le bullatacine exerce un effet de neutralisation et d'élimination puissant sur les SIV ou VIH.
PCT/CN2004/000611 2003-06-05 2004-06-07 Utilisation de bullatacine dans la fabrication de medicaments anti-sida WO2004108128A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN03126770.X 2003-06-05
CNB03126770XA CN1182848C (zh) 2003-06-05 2003-06-05 布拉他辛在制备抑制艾滋病病毒的药物中的应用

Publications (1)

Publication Number Publication Date
WO2004108128A1 true WO2004108128A1 (fr) 2004-12-16

Family

ID=29591091

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2004/000611 WO2004108128A1 (fr) 2003-06-05 2004-06-07 Utilisation de bullatacine dans la fabrication de medicaments anti-sida

Country Status (2)

Country Link
CN (1) CN1182848C (fr)
WO (1) WO2004108128A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7624963B2 (en) * 2007-02-16 2009-12-01 Fisher Controls International Llc Valve flow adjustment device
CN101259116B (zh) * 2008-04-28 2010-06-09 贵州正鑫实业有限公司 一种含有布拉他辛部位药精品的外用给药制剂

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229419A (en) * 1989-04-11 1993-07-20 Purdue Research Foundation Chemotherapeutically active acetogenins
US5607673A (en) * 1995-04-20 1997-03-04 C.S.S.A.H.A., Inc. Purified extract of uvaria brevistipitata and a process for obtaining the purified extract therefor
CN1255494A (zh) * 1999-11-24 2000-06-07 杨仁洲 清除hiv病毒、治疗艾滋病的聚乙酰精宁

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229419A (en) * 1989-04-11 1993-07-20 Purdue Research Foundation Chemotherapeutically active acetogenins
US5607673A (en) * 1995-04-20 1997-03-04 C.S.S.A.H.A., Inc. Purified extract of uvaria brevistipitata and a process for obtaining the purified extract therefor
CN1255494A (zh) * 1999-11-24 2000-06-07 杨仁洲 清除hiv病毒、治疗艾滋病的聚乙酰精宁

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAN J. ET AL.: "Bllatacin-potent anticancer agent", CHINESE TRADITIONAL AND HERBAL DRUGS, vol. 33, no. 4, 2002, pages 380 - 382 *
YANG R, ET AL.: "Studies on the chemical constituents of Annona squamosa (7)", ACTA BOTANICA YUNNANICA, vol. 22, no. 1, 2000, pages 71 - 74 *

Also Published As

Publication number Publication date
CN1182848C (zh) 2005-01-05
CN1460473A (zh) 2003-12-10

Similar Documents

Publication Publication Date Title
WO2007041487A3 (fr) Peptides inhibiteurs d'infections virales
WO2004011478A3 (fr) Nucleosides d de 7-deaza antiviraux et leurs utilisations
WO2004071426A3 (fr) Composes destines au traitement d'une infection virale
WO2004096818A3 (fr) Procede et compositions pour l'identification de composes therapeutiques anti-vih
WO2001077091A3 (fr) Inhibiteurs de polymerases ns5b vhc
WO2007038507A3 (fr) 4'-nucleosides modifies utiles comme agents antiviraux
WO2006081554A3 (fr) Pyrrolidones a substitution phenyle
EA200700243A1 (ru) Способы лечения гепатита с
WO2009094190A3 (fr) Méthodes de traitement d’infections virales
WO2007041632A3 (fr) Procedes et compositions pharmaceutiques pour traiter et prevenir une infection par le virus de l'hepatite c
WO2006050489A3 (fr) Methodes d'encapsulation, d'inactivation, et d'elimination d'infections virales par administration de compositions aux voies respiratoires
WO2006034001A3 (fr) Procedes de traitement de l'infection par vih
TW200510343A (en) Substituted dihydroquinazolines
WO2009036341A3 (fr) Compositions et procédés liés à l'inhibition de la vih protéase
WO2003055896A3 (fr) 7-deaza l-nucleosides en tant qu'antiviraux
WO2001010456A3 (fr) Peptides bloquant les infections virales et procedes d'utilisation correspondants
WO2007019098A3 (fr) Inhibiteurs de l'integrase du vih
WO2007002639A3 (fr) Agents anti-hepacivirus non-nucleoside et utilisations de ceux-ci
WO2003015708A3 (fr) Traitement de l'infection par le vih et composition a cet effet
EP2495252A3 (fr) Formes solubles de glycoproteine G des virus hendra et nipah
WO2006043153A3 (fr) Utilisation de chelateurs d'ions de zinc et de cuivre pour le traitement d'infections causees par des virus vehicules par le sang
WO2008045017A3 (fr) Inhibiteurs des virus sars et ebola, leur utilisation, et procédés pour les découvrir
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
WO2001057072A3 (fr) Peptides antiviraux pharmacologiquement actifs et leurs methodes d'utilisation
WO2007057436A3 (fr) L’interferon dans la grippe

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase